Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab bioavailability and pharmacodynamics in dermal interstitial fluid in adults with atopic dermatitis
2018-003642-17Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dupilumab in atopic dermatitis (AD), sponsored by Medical University of Graz. Primary endpoint: Cytokines and chemokines in blood and dermal interstitial fluid. Started Sep 2018; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2018-003642-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003642-17.